Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
View Older Stories View More Recent Stories
-
Form N-PX ARGUS INVESTORS' COUNSEL For: Jun 30
-
Amazon river levels fall due to lack of rain, hurting navigation
-
CrowdStrike Holdings (CRWD) PT Lowered to $325 at Argus
-
Argus Upgrades Newmont Mining Corp. (NEM) to Buy
-
Argus Upgrades Barrick Gold Corp. (GOLD) to Buy
-
Reolink Launches Home Hub: Best Wireless Security Center for Local Storage and Multi-Device Management Reviewed by Compare Before Buying
-
Romanian government plans drought insurance scheme for farmers
-
Argus Upgrades Xcel Energy (XEL) to Buy
-
Argus Downgrades Wayfair (W) to Hold
-
Exchange Bank Declares Third Quarter Cash Dividend
-
Reolink to Unveil New Flagship Product at IFA Berlin 2024
-
Rod Hershberger appointed to MITER Brands’ board
-
Apollo Global Management (APO) PT Lowered to $125 at Argus
-
Argus Downgrades Vontier (VNT) to Hold
-
Introducing PlaxidityX: Argus Cyber Security Ltd. Unveils New Company Name to Reflect Accelerated Business Growth, Expanded Vision and Market Leadership
-
Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results
-
Asia spot LNG prices remain at 7-month high amid Russian supply concerns
-
NGL Energy Partners LP Announces First Quarter Fiscal 2025 Financial Results
-
Altus Group Reports Q2 2024 Financial Results and Quarterly Dividend
-
Ring Energy Announces Second Quarter 2024 Results, Provides Guidance for Third Quarter and Updates Full Year 2024 Outlook
-
Permian Resources Announces Strong Second Quarter 2024 Results and Increased Full Year Guidance
-
Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
-
Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
-
Delek US Holdings Reports Second Quarter 2024 Results
-
IVIX Grows Leadership Team with New Chief Revenue Officer and Other Senior Hires
-
Thrive Aviation Elevates to WYVERN Wingman PRO!
-
US bank stocks tumble; weak economic data sparks recession fears
-
Argus Downgrades Digital Realty Trust (DLR) to Hold
-
PBF Energy Announces Second Quarter 2024 Results and Declares Dividend of $0.25 per Share
-
Bernstein and Argus fuel PayPal optimism with stock rating upgrades
-
PayPal's turnaround plan faces challenges from competition, analysts say
-
Costamare Inc. Reports Results for The Second Quarter and Six-Month Period Ended June 30, 2024
-
Form SC 13D/A NASDAQ, INC. Filed by: Argus Seller, LP
-
Enterprise Reports Results for Second Quarter 2024
-
Sherritt Reports Second Quarter 2024 Results; Metals and Power Deliver Strong Performance; Net Direct Cash Cost Significantly Improved
-
NASDAQ (NDAQ) Prices Secondary Offering of Nasdaq Common Stock at $65.30 Per Share
-
Nasdaq Announces Pricing of Secondary Offering of Nasdaq Common Stock
-
NASDAQ (NDAQ) Announces Launch of Secondary Offering of Nasdaq Common Stock
-
Nasdaq Announces Launch of Secondary Offering of Nasdaq Common Stock
-
Unilever plc (UL) PT Raised to $70 at Argus
-
Lazard (LAZ) PT Raised to $54 at Argus
-
Celestica (CLS) PT Raised to $58 at Argus
-
Sanofi-Aventis (SNY) PT Raised to $60 at Argus
-
Argus Reiterates Buy Rating on Tesla (TSLA), PT $286
-
MSCI Inc. (MSCI) PT Raised to $600 at Argus
-
KLA Corporation (KLAC) PT Raised to $875 at Argus
-
Exchange Bank Announces Second Quarter 2024 Earnings
-
General Motors (GM) PT Raised to $54 at Argus
-
Fiserv (FI) PT Raised to $187 at Argus
-
Argus Downgrades Zions Bancorp (ZION) to Hold

